Ocuphire Pharma Inc. buy BiotechBee
Start price
10.01.23
/
50%
€3.20
Target price
31.12.25
€6.00
Performance (%)
-28.13%
End price
26.01.23
€2.30
Summary
This prediction ended on 26.01.23 with a price of €2.30. The prediction for Ocuphire Pharma Inc. disappointed with a performance of -28.13%. BiotechBee has a follow-up prediction for Ocuphire Pharma Inc. where he still thinks Ocuphire Pharma Inc. is a Buy. BiotechBee has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Ocuphire Pharma Inc. | 5.967% | 5.967% | -50.803% |
iShares Core DAX® | -1.180% | 0.780% | 12.701% |
iShares Nasdaq 100 | -2.823% | -2.419% | 28.746% |
iShares Nikkei 225® | -3.908% | 1.574% | 11.146% |
iShares S&P 500 | -1.012% | -0.335% | 27.036% |
According to BiotechBee what are the pros and cons of Ocuphire Pharma Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Ocuphire Pharma Inc. diskutieren
Buy mit Kursziel 6,0
In the thread Trading Ocuphire Pharma Inc.
Buy beendet
Current prediction by BiotechBee for Ocuphire Pharma Inc.
Ocuphire Pharma Inc.
Start price
Target price
Perf. (%)
€3.71
03.09.23
03.09.23
€5.00
30.11.25
30.11.25
-52.06%
18.07.24
18.07.24
Could be very worthwhile Investment >20% year
Stopped prediction by BiotechBee for Ocuphire Pharma Inc.
Ocuphire Pharma Inc.
Start price
Target price
Perf. (%)
€3.31
03.01.23
03.01.23
€5.00
31.03.25
31.03.25
-3.24%
10.01.23
10.01.23
Could be very worthwhile Investment >20% year